STUDIES ON THE INTERACTION BETWEEN PLASMINOGEN-ACTIVATOR INHIBITOR-1 AND VITRONECTIN

被引:13
|
作者
SIGURDARDOTTIR, O [1 ]
WIMAN, B [1 ]
机构
[1] KAROLINSKA HOSP,DEPT CLIN CHEM,S-10401 STOCKHOLM 60,SWEDEN
关键词
D O I
10.1016/0268-9499(92)90044-I
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Recently, the functionally active form of plasminogen activator inhibitor type-1 (PAI-1) was found to bind to vitronectin both in plasma and in extracellular matrix. In the present study the formation of the complex between functionally active PAI-1 and vitronectin has been studied using vitronectin-coated microtitre plates. PAI-1 bound to vitronectin in the microtitre plates was quantified using HRP-conjugated monoclonal antibodies towards PAI-1. Even at PAI-1 concentrations of about 1 pmol/l the binding to the vitronectin-coated plates seem to be quantitative suggesting high affinity. In contrast, with 'latent' PAI-1 at similar molar concentrations, no binding was observed. The effects of pH, NaCl, KBr, KSCN, urea, guanidinium chloride and certain amino acids were studied on the interaction between active PAI-1 and vitronectin. The interaction was not affected at a wide pH range or by increasing the ionic strength by addition of NaCl, suggesting that the binding is more complicated than just an ionic binding. In addition, no effect was observed on the complex formation by 2 mol/l KBr. In contrast, 0.5 mol/l KSCN almost completely abolished complex formation. Furthermore, arginine and guanidinium chloride, both dissociated the complex readily. Half maximal binding was obtained at about 0.3 mol/l for both substances. In contrast hardly any effect was obtained with epsilon aminocaproic acid (EACA) or lysine in concentrations up to 1.6 mol/l. Our results suggest that guanidine groups and most likely also hydrophobic interactions are involved in the binding of the active form of PAI-1 to vitronectin.
引用
收藏
页码:27 / 32
页数:6
相关论文
共 50 条
  • [21] ON THE TARGET SPECIFICITY OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 - THE ROLE OF HEPARIN, VITRONECTIN, AND THE REACTIVE SITE
    KEIJER, J
    LINDERS, M
    WEGMAN, JJ
    EHRLICH, HJ
    MERTENS, K
    PANNEKOEK, H
    BLOOD, 1991, 78 (05) : 1254 - 1261
  • [22] VITRONECTIN EFFECTS ON RECOMBINANT PLASMINOGEN-ACTIVATOR INHIBITOR-1 - STRUCTURAL AND FUNCTIONAL-ANALYSIS
    REILLY, TM
    FORSYTHE, MS
    DWIVEDI, AM
    WALTON, HL
    DUKE, JL
    WADE, DL
    KNABB, RM
    MOUSA, SA
    FIBRINOLYSIS, 1992, 6 (03) : 167 - 171
  • [23] DETERMINATION OF THE VITRONECTIN BINDING-SITE ON PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-1)
    VANMEIJER, M
    GEBBINK, RK
    PREISSNER, KT
    PANNEKOEK, H
    FEBS LETTERS, 1994, 352 (03) : 342 - 346
  • [24] PLASMINOGEN-ACTIVATOR INHIBITOR-1 AND PLASMINOGEN-ACTIVATOR INHIBITOR-2 IN VARIOUS DISEASE STATES
    KRUITHOF, EKO
    GUDINCHET, A
    BACHMANN, F
    THROMBOSIS AND HAEMOSTASIS, 1988, 59 (01) : 7 - 12
  • [25] HUMAN PLASMINOGEN-ACTIVATOR INHIBITOR-1 DEFICIENCY
    FAY, WP
    SHAPIRO, AD
    SHIH, JL
    SCHLEEF, RR
    GINSBURG, D
    CIRCULATION, 1992, 86 (04) : S12 - S12
  • [26] INTERACTION OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR AND PLASMINOGEN-ACTIVATOR INHIBITOR-1 ON THE SURFACE OF ENDOTHELIAL-CELLS
    SAKATA, Y
    OKADA, M
    NORO, A
    MATSUDA, M
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1988, 263 (04) : 1960 - 1969
  • [27] THE PHARMACOKINETICS OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 IN THE RABBIT
    MAYER, EJ
    FUJITA, T
    GARDELL, SJ
    SHEBUSKI, RJ
    REILLY, CF
    BLOOD, 1990, 76 (08) : 1514 - 1520
  • [28] DETERMINANTS OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 ACTIVITY IN TREATED NIDDM AND ITS RELATION TO A POLYMORPHISM IN THE PLASMINOGEN-ACTIVATOR INHIBITOR-1 GENE
    PANAHLOO, A
    MOHAMEDALI, V
    LANE, A
    GREEN, F
    HUMPHRIES, SE
    YUDKIN, JS
    DIABETES, 1995, 44 (01) : 37 - 42
  • [29] The use of fluorescent probes to characterize conformational changes in the interaction between vitronectin and plasminogen activator inhibitor-1
    Gibson, A
    Baburaj, K
    Day, DE
    Verhamme, I
    Shore, JD
    Peterson, CB
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (08) : 5112 - 5121
  • [30] PLASMIN CLEAVAGE OF VITRONECTIN - IDENTIFICATION OF THE SITE AND CONSEQUENT ATTENUATION IN BINDING PLASMINOGEN-ACTIVATOR INHIBITOR-1
    CHAIN, D
    KREIZMAN, T
    SHAPIRA, H
    SHALTIEL, S
    FEBS LETTERS, 1991, 285 (02): : 251 - 256